Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Measurement-based Care for Depression in HIV Patients
NCT02916238Phase 4Completed
- Sponsor
- Florida International University
- Start
- Feb 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluoxetine in major depressive disorder (MDD) (2 arms), sponsored by Florida International University. Primary endpoint: Remission of Depression at 6 months. Started Feb 2014; status: completed.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02916238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02916238.